Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2

Danwei Huangfu1, Kenji Osafune, René Maehr

  • 1Department of Stem Cell and Regenerative Biology, Howard Hughes Medical Institute, Harvard Stem Cell Institute, Harvard University, 7 Divinity Avenue, Cambridge, Massachusetts 02138, USA.

Nature Biotechnology
|October 14, 2008
PubMed

Insights

Valproic acid (VPA) enables reprogramming of human fibroblasts into induced pluripotent stem (iPS) cells using only Oct4 and Sox2. This chemical reprogramming method avoids oncogenes, enhancing safety for therapeutic applications.

Area of Science:

  • Stem cell biology
  • Epigenetics
  • Molecular medicine

Background:

  • Somatic cell reprogramming to induced pluripotent stem (iPS) cells is crucial for regenerative medicine.
  • Current methods often rely on viral transgenes, including oncogenes like c-Myc and Klf4, limiting therapeutic potential due to safety concerns.
  • Low reprogramming efficiency hinders mechanistic studies and clinical translation.

Purpose of the Study:

  • To investigate if chemical modifiers can improve reprogramming efficiency and safety.
  • To develop a method for generating human iPS cells using fewer factors and avoiding oncogenes.
  • To assess the pluripotency and characteristics of chemically induced iPS cells.

Main Methods:

  • Utilized valproic acid (VPA), a histone deacetylase inhibitor, as a chemical reprogramming enhancer.
  • Employed only two reprogramming factors: Oct4 and Sox2, omitting c-Myc and Klf4.
  • Derived and characterized induced pluripotent stem cells from primary human fibroblasts.

Main Results:

  • Valproic acid (VPA) enabled efficient reprogramming of human fibroblasts with only Oct4 and Sox2.
  • The generated two-factor induced iPS cells exhibited pluripotency comparable to embryonic stem (ES) cells.
  • Global gene expression and epigenetic profiles of these iPS cells mirrored those of human ES cells.
  • The method successfully avoided the use of oncogenes c-Myc and Klf4.

Conclusions:

  • Histone deacetylase inhibition with VPA facilitates safer and more efficient reprogramming.
  • Reprogramming with Oct4 and Sox2, enhanced by VPA, offers a promising alternative for generating clinical-grade iPS cells.
  • Chemical reprogramming holds potential for safer and more practical therapeutic applications of stem cells.

Related Concept Videos

Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...